<?xml version='1.0' encoding='utf-8'?>
<document xmlns="https://code.dccouncil.us/schemas/dc-library" xmlns:codified="https://code.dccouncil.us/schemas/codified" xmlns:codify="https://code.dccouncil.us/schemas/codify" xmlns:xi="http://www.w3.org/2001/XInclude" id="D.C. Law 22-31">
  <num type="law">22-31</num>
  <num type="bill">22-414</num>
  <num type="act">22-150</num>
  <heading type="short">Access to Emergency Epinephrine in Schools Clarification Temporary Amendment Act of 2017</heading>
  <heading type="long">To amend, on a temporary basis, the Student Access to Treatment Act of 2007 to authorize employees and agents of public schools certified under the Office of the State Superintendent of Education's epinephrine administration training program to administer a designated epinephrine auto-injector to a student to whom it is prescribed.</heading>
  <meta>
    <effective>2017-12-07</effective>
    <temporary/>
    <citations>
      <citation type="law" url="http://lims.dccouncil.us/Download/38680/B22-0414-SignedAct.pdf">D.C. Law 22-31</citation>
      <citation type="register">64 DCR 10736</citation>
    </citations>
    <history>
      <vote date="2017-09-19" reading="First"/>
      <vote date="2017-10-03" reading="Final"/>
      <enacted>2017-10-18</enacted>
      <summary/>
      <committee>Retained by the Council</committee>
    </history>
  </meta>
  <text>BE IT ENACTED BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this act may be cited as the "Access to Emergency Epinephrine in Schools Clarification Temporary Amendment Act of 2017".</text>
  <section>
    <num>2</num>
    <text>The Student Access to Treatment Act of 2007, effective February 2, 2008 (D.C. Law 17-107; D.C. Official Code § 38-651.01 <em>et seq.</em>), is amended as follows:</text>
    <para>
      <num>(a)</num>
      <text>Section 2 (D.C. Official Code § 38-651.01) is amended as follows:</text>
      <para>
        <num>(1)</num>
        <text>The existing paragraph (1) is redesignated as paragraph (1A).</text>
      </para>
      <para>
        <num>(2)</num>
        <text>A new paragraph (1) is added to read as follows:</text>
        <include lvl="1">
          <para>
            <num>(1)</num>
            <text>"Designated epinephrine auto-injector" means a disposable drug delivery system with a spring-activated needle, which is obtained with a prescription for a particular person that is designed for the emergency administration of epinephrine to a person suffering an episode of anaphylaxis.</text>
          </para>
        </include>
        <aftertext>.</aftertext>
        <codify:temporary doc="D.C. Code" path="§38-651.01"/>
      </para>
    </para>
    <para>
      <num>(b)</num>
      <text>Section 5a (D.C. Official Code § 38-651.04a) is amended as follows:</text>
      <para>
        <num>(1)</num>
        <text>Subsection (b)(2) is amended by striking the phrase "an undesignated" and inserting the phrase "a designated or undesignated" in its place.</text>
      </para>
      <para>
        <num>(2)</num>
        <text>A new subsection (e) is added to read as follows:</text>
        <include>
          <para>
            <num>(e)</num>
            <text>An employee or agent of a public school who is certified pursuant to this section may administer a designated epinephrine auto-injector to the student to whom it is prescribed, who the employee or agent believes in good faith to be suffering or about to suffer an anaphylactic episode.</text>
          </para>
        </include>
        <aftertext>.</aftertext>
      </para>
      <codify:temporary doc="D.C. Code" path="§38-651.04a"/>
    </para>
  </section>
  <section>
    <num>3</num>
    <heading>Fiscal impact statement.</heading>
    <text>The Council adopts the fiscal impact statement of the Budget Director as the fiscal impact statement required by section 4a of the General Legislative Procedures Act of 1975, approved October 16, 2006 (120 Stat. 2038; D.C. Official Code § 1-301.47a).</text>
  </section>
  <section>
    <num>4</num>
    <heading>Effective date.</heading>
    <para>
      <num>(a)</num>
      <text>This act shall take effect following approval by the Mayor (or in the event of veto by the Mayor, action by the Council to override the veto), a 30-day period of congressional review as provided in section 602(c)(1) of the District of Columbia Home Rule Act, approved December 24, 1973 (87 Stat. 813; D.C. Official Code § 1-206.02(c)(1)), and publication in the District of Columbia Register.</text>
    </para>
    <para>
      <num>(b)</num>
      <text>This act shall expire after 225 days of its having taken effect.</text>
    </para>
  </section>
</document>
